Diagnostic and Interventional Radiology
Interventional Radiology - Review

Bronchial artery embolization in hemoptysis: a systematic review


Department of Radiodiagnosis All India Institute of Medical Sciences, New Delhi, India.

Diagn Interv Radiol 2017; 23: 307-317
DOI: 10.5152/dir.2017.16454
Read: 1967 Downloads: 545 Published: 03 September 2019


We systematically reviewed the role of bronchial artery embolization (BAE) in hemoptysis. Literature search was done for studies on BAE published between 1976 and 2016. Twenty-two studies published in English, with sample size of at least 50 patients, reporting indications, technique, efficacy, and follow-up were included in the final analysis. Common indications for BAE included tuberculosis (TB), post-tubercular sequelae, bronchiectasis, and aspergillomas. Most common embolizing agent used was polyvinyl alcohol (size, 300–600 μm) with increasing use of glue in recent years. Overall immediate clinical success rate of BAE, defined as complete cessation of hemoptysis, varied from 70%–99%. However, recurrence rate remains high, ranging from 10%–57%, due to incomplete initial embolization, recanalization of previously embolized arteries, and recruitment of new collaterals. Presence of nonbronchial systemic collaterals, bronchopulmonary shunting, aspergillomas, reactivation TB, and multidrug resistant TB were associated with significantly higher recurrence rates (P < 0.05). Rate of major complications remained negligible and stable over time with median incidence of 0.1% (0%–6.6%). Despite high hemoptysis recurrence rates, BAE continues to be the first-line, minimally invasive treatment of hemoptysis in emergency settings, surgically unfit patients, or in patients with diffuse or bilateral lung disease.


You may cite this article as: Panda A, Bhalla AS, Goyal A. Bronchial artery embolization in hemoptysis: a systematic review.  Diagn Interv Radiol 2017; 23:307–317.

EISSN 1305-3612